U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
178621178621Safety Study of Rituximab (Rituxan®) in Chronic UrticariaTerminatedNo Results AvailableUrticariaDrug: Rituximabhttps://ClinicalTrials.gov/show/NCT00216762
178622178622Efficacy and Safety of Cilostazol for the Indication of CSPSCompletedNo Results AvailableCerebral Infarctionhttps://ClinicalTrials.gov/show/NCT00216749
178623178623Oral Dexamethasone for Treatment of MigraineCompletedHas ResultsMigraineDrug: Dexamethasone|Drug: placebohttps://ClinicalTrials.gov/show/NCT00216736
178624178624Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar DisorderCompletedNo Results AvailableSchizophrenia|Bipolar DisorderDrug: Aripiprazolehttps://ClinicalTrials.gov/show/NCT00216723
178625178625Evaluation of the Healthy Families Alaska ProgramCompletedNo Results AvailableChild AbuseBehavioral: Home Visitinghttps://ClinicalTrials.gov/show/NCT00216710
178626178626An Extension Study to Provide Bortezomib to Patients With Relapsed or Refractory Multiple Myeloma Who Previously Participated in a Bortezomib Phase I/II Study and Who May Benefit From Re-Treatment With or Continuation of Bortezomib TherapyCompletedNo Results AvailableMultiple MyelomaDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00216697
178627178627Phase III Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Chronic Intractable Pain- Assessment of Effectiveness, Safety and PharmacokineticsCompletedNo Results AvailablePain, IntractableDrug: fentanylhttps://ClinicalTrials.gov/show/NCT00216684
178628178628Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute EpisodeCompletedHas ResultsSchizophreniaDrug: early initiation of treatment with Risperdal Consta|Drug: routine initiation of treatment with Risperdal Constahttps://ClinicalTrials.gov/show/NCT00216671
178629178629Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -CompletedNo Results AvailablePain, IntractableDrug: fentanylhttps://ClinicalTrials.gov/show/NCT00216658
178630178630Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior PlaCompletedNo Results AvailableOvarian NeoplasmsDrug: doxorubicin hydrochloridehttps://ClinicalTrials.gov/show/NCT00216645
178631178631A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)CompletedNo Results AvailableSchizophrenia|Psychotic DisordersDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00216632
178632178632The Prolonged Use of Topiramate for Preventing Migraine HeadachesCompletedNo Results AvailableMigraineDrug: Topiramate|Drug: Topiramate - Placebohttps://ClinicalTrials.gov/show/NCT00216619
178633178633The Effectiveness and Safety of Topiramate on Prevention of Chronic MigraineCompletedNo Results AvailableMigraineDrug: topiramatehttps://ClinicalTrials.gov/show/NCT00216606
178634178634Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled StudyCompletedNo Results AvailableDementia|Alzheimer DiseaseDrug: galantamine hydrobromidehttps://ClinicalTrials.gov/show/NCT00216593
178635178635A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset PsychosisCompletedNo Results AvailableSchizophreniaDrug: Risperidone, long-acting injectablehttps://ClinicalTrials.gov/show/NCT00216580
178636178636Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic EpilepsyCompletedNo Results AvailableEpilepsy, RolandicDrug: topamaxhttps://ClinicalTrials.gov/show/NCT00216567
178637178637The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar ManiaCompletedNo Results AvailableBipolar DisorderDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00216554
178638178638A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving ChemotherapyCompletedNo Results AvailableAnemia|NeoplasmsDrug: epoetin alfahttps://ClinicalTrials.gov/show/NCT00216541
178639178639A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone MicrospheresCompletedNo Results AvailableSchizophreniaDrug: risperidonehttps://ClinicalTrials.gov/show/NCT00216528
178640178640The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer TypeCompletedNo Results AvailableAlzheimer DiseaseDrug: galantamine hydrobromidehttps://ClinicalTrials.gov/show/NCT00216515
178641178641A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's DiseaseCompletedNo Results AvailableAlzheimer Disease|Dementia|Mental Disorders|Brain DiseasesDrug: galantamine hydrobromidehttps://ClinicalTrials.gov/show/NCT00216502
178642178642A Study of the Safety of Rabeprazole Administered to Adults With Gastroesophageal Reflux Disease (GERD)CompletedNo Results AvailableGastroesophageal Reflux|HeartburnDrug: rabeprazole sodiumhttps://ClinicalTrials.gov/show/NCT00216489
178643178643A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective DisorderCompletedHas ResultsSchizophrenia|Psychotic DisordersDrug: Aripiprazole|Drug: Risperidone Long Acting Injectable (LAI)|Drug: Quetiapinehttps://ClinicalTrials.gov/show/NCT00216476
178644178644Safety and Tolerability of Varying Load and Dose of ISIS 301012 in People With Elevated LDL-cholesterol LevelsCompletedNo Results AvailableHypercholesterolemiaDrug: ISIS 301012 or Placebo|Drug: ISIS 301012 or Placebo|Drug: ISIS 301012 or Placebo|Drug: ISIS 301012 or Placebo|Drug: ISIS 301012 or Placebohttps://ClinicalTrials.gov/show/NCT00216463
178645178645Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.CompletedNo Results AvailableHelicobacter Infections|Bacterial InfectionsDrug: rabeprazole sodiumhttps://ClinicalTrials.gov/show/NCT00216450
178646178646Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or CholangiocarcinomaTerminatedNo Results AvailableCancer of LiverDrug: Capecitabine (Xeloda)https://ClinicalTrials.gov/show/NCT00216437
178647178647Capecitabine (Xeloda) and Radiation for Patients With Rectosigmoid CarcinomaTerminatedNo Results AvailableColorectal CancerDrug: Capecitabine (Xeloda)https://ClinicalTrials.gov/show/NCT00216424
178648178648Effects on Quality of Life Following Dysport Treatment in Post-Stroke Spasticity of the ArmCompletedNo Results AvailableCerebrovascular Accident|Muscle SpasticityDrug: Botulinum type A toxin (Dysport)https://ClinicalTrials.gov/show/NCT00216411
178649178649Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LARCompletedNo Results AvailableAcromegalyDrug: Lanreotide (Autogel formulation)https://ClinicalTrials.gov/show/NCT00216398
178650178650A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary TuberculosisRecruitingNo Results AvailableTuberculosisDrug: Gatifloxacin combined regimenhttps://ClinicalTrials.gov/show/NCT00216385

* Görseller ve İçerik tekif hakkına sahip olabilir